Home > Insider Trading > Filing (0001213900-19-005844)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1506251	Citius Pharmaceuticals Inc.	CTXR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463414	L Leonard Mazur	C/O Citius Pharmaceuticals, Inc. 11 Commerce Drive, 1St Floor Cranford NJ 07016	Executive Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-03	1,165,048	$1.55	8,020,643	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2019-04-03	1,165,048	$0.00	1,165,048	$1.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,615,048		2021-04-05	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Options to Purchase Common Stock	$3.45	2027-09-13	40,000	40,000	Direct
Common Stock	Warrant to Purchase Common Stock	$6.15	2019-06-12	19,614	19,614	Direct
Common Stock	Warrant to Purchase Common Stock	$9.90	2019-09-30	3,171	3,171	Direct
Common Stock	Warrant to Purchase Common Stock	$9.90	2020-01-08	4,984	4,984	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-08-18	35,211	35,211	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-11-02	20,783	20,783	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-11-20	20,664	20,664	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2021-01-08	13,679	13,679	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2021-03-14	4,210	4,210	Direct
Common Stock	Warrant to Purchase Common Stock	$6.15	2021-03-15	18,106	18,106	Direct
Common Stock	Warrant to Purchase Common Stock	$4.13	2022-08-08	421,400	421,400	Direct
Common Stock	Warrant to Purchase Common Stock	$4.13	2022-08-08	11,000	11,000	Direct
Common Stock	Options to Purchase Common Stock	$6.75	2024-09-12	220,000	220,000	Direct
Common Stock	Warrant to Purchase Common Stock	$4.63	2023-06-19	106,553	106,553	Direct
Common Stock	Warrant to Purchase Common Stock	$2.86	2023-09-29	167,504	167,504	Direct
Common Stock	Warrant to Purchase Common Stock	$1.15	2023-08-14	3,137,255	3,137,255	Direct
Common Stock	Options to Purchase Common Stock	$1.62	2028-09-04	150,000	150,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-09-13	40,000	40,000	Direct
2019-06-12	19,614	19,614	Direct
2019-09-30	3,171	3,171	Direct
2020-01-08	4,984	4,984	Direct
2020-08-18	35,211	35,211	Direct
2020-11-02	20,783	20,783	Direct
2020-11-20	20,664	20,664	Direct
2021-01-08	13,679	13,679	Direct
2021-03-14	4,210	4,210	Direct
2021-03-15	18,106	18,106	Direct
2022-08-08	421,400	421,400	Direct
2022-08-08	11,000	11,000	Direct
2024-09-12	220,000	220,000	Direct
2023-06-19	106,553	106,553	Direct
2023-09-29	167,504	167,504	Direct
2023-08-14	3,137,255	3,137,255	Direct
2028-09-04	150,000	150,000	Direct

Footnotes

One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
The warrant is fully vested and exercisable immediately.
The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.
The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.
One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.